Adipocyte PI3K links adipostasis with baseline insulin secretion at fasting through an adipoincretin effect

Insulin-PI3K signaling controls Insulin secretion. Understanding this feedback mechanism is crucial for comprehending how Insulin functions. However, the role of adipocyte insulin-PI3K signaling in controlling Insulin secretion in vivo remains unclear. Using adipocyte-specific PI3Kα knockout mice (PI3Kα^AdQ) and a panel of isoform-selective PI3K inhibitors, we show that PI3Kα and PI3Kβ activities are functionally redundant in adipocyte Insulin signaling. PI3Kβ-selective inhibitors have no effect on adipocyte Akt phosphorylation in control mice but blunt it in adipocytes of PI3Kα^AdQ mice, demonstrating adipocyte-selective pharmacological PI3K inhibition in the latter. Acute adipocyte-selective PI3K inhibition increases serum free fatty acid (FFA) and potently induces Insulin secretion. We name this phenomenon the adipoincretin effect. The adipoincretin effect operates in fasted mice with increasing FFA and decreasing glycemia, indicating that it is not primarily a control system for blood glucose. This feedback control system defines the rates of adipose tissue lipolysis and chiefly controls basal Insulin secretion during fasting.

AKT; CP: Metabolism; PI3K; diabetes; growth factors; incretin; insulin; insulin resistance; insulin secretion; mTOR; obesity.